Sandy Spring Bank Esperion Therapeutics, Inc. Transaction History

Sandy Spring Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$25.12 - $36.89 $3,768 - $5,533	-150 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$24.2 - $35.76 $1,936 - $2,860	80 Added 114.29%	150 $4,000
Q3 2020 Nov 09, 2020	BUY	$31.18 - $52.71 $1,559 - $2,635	50 Added 250.0%	70 $3,000
Q2 2020 Aug 12, 2020	SELL	$30.04 - $51.31 $901 - $1,539	-30 Reduced 60.0%	20 $1,000
Q1 2020 May 01, 2020	BUY	$27.44 - $73.84 $1,372 - $3,692	50 New	50 $2,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

Stay updated on Sandy Spring Bank with notifications on news.